You are here: Home » International » News » Companies
Business Standard

J&J to contribute up to $5 billion to potential US opioid settlement

The New Brunswick, New Jersey-based drugmaker had agreed last October to a $4 billion settlement framework negotiated with a group of state attorneys general

Johnson & Johnson


Photo: Reuters
Photo: Reuters

By Nate Raymond

(Reuters) - said on Tuesday it will contribute up to $1 billion more to a potential settlement of lawsuits alleging it and other fueled the U.S. opioid epidemic, bringing its total payment to $5 billion.

The New Brunswick, New Jersey-based drugmaker had agreed last October to a $4 billion settlement framework negotiated with a group of state attorneys general.

That proposal also called for the drug distributors McKesson Corp , Cardinal Health and AmerisourceBergen to pay a combined $18 billion, but the framework met resistance from some states and local governments.

Negotiations have been ongoing since then, and the dollar amounts have been shifting. J&J in a statement said the additional $1 billion reflected continued negotiations and said additional terms are being finalized.

Paul Hanly, a lead attorney for local governments pursuing federal lawsuits against opioid manufacturers and distributors, said in a statement the plaintiffs' lawyers were "very pleased" with J&J's agreement to resolve the cases.

"We are hopeful other defending the numerous litigations will see the wisdom of this step forward," he said.

Representatives for the distributors and several state attorneys general did not respond to requests for comment.

More than 3,000 lawsuits have been filed nationally largely by states, counties and municipalities seeking to hold drug responsible for the U.S. opioid addiction epidemic.

The lawsuits generally accuse drugmakers including J&J of deceptively marketing opioids and distributors of ignoring red flags indicating the painkillers were being diverted for improper uses.

The companies including J&J deny wrongdoing. J&J is separately appealing a $465 million judgment the state of Oklahoma won against it in the first case to go to trial in the litigation.


(Reporting by Nate Raymond in Boston; Editing by Chris Reese and Richard Chang)

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Dear Reader,

Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

First Published: Wed, October 14 2020. 06:49 IST